Operating Margin of BioNexus Gene Lab Corp from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
BioNexus Gene Lab Corp quarterly and annual Operating Margin in % history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • BioNexus Gene Lab Corp Operating Margin for the quarter ending 30 Sep 2025 was -25%, a 155% decline year-over-year.
  • BioNexus Gene Lab Corp annual Operating Margin for 2024 was -17%, a 38% increase from 2023.
  • BioNexus Gene Lab Corp annual Operating Margin for 2023 was -27%, a 896% decline from 2022.
  • BioNexus Gene Lab Corp annual Operating Margin for 2022 was -2.7%, a 134% decline from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

BioNexus Gene Lab Corp Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -25% -15% -155% 01 Jul 2025 30 Sep 2025
Q2 2025 -31% -8.5% -37% 01 Apr 2025 30 Jun 2025
Q1 2025 -23% +4% +15% 01 Jan 2025 31 Mar 2025
Q4 2024 -17% +10% +38% 01 Oct 2024 31 Dec 2024
Q3 2024 -9.7% +19% +66% 01 Jul 2024 30 Sep 2024
Q2 2024 -23% -18% -362% 01 Apr 2024 30 Jun 2024
Q1 2024 -27% -23% -632% 01 Jan 2024 31 Mar 2024
Q4 2023 -27% -24% -896% 01 Oct 2023 31 Dec 2023
Q3 2023 -29% -29% -10102% 01 Jul 2023 30 Sep 2023
Q2 2023 -4.9% -8.7% -229% 01 Apr 2023 30 Jun 2023
Q1 2023 -3.7% -9.4% -163% 01 Jan 2023 31 Mar 2023
Q4 2022 -2.7% -11% -134% 01 Oct 2022 31 Dec 2022
Q3 2022 0.29% -5.7% -95% 01 Jul 2022 30 Sep 2022
Q2 2022 3.8% -1.4% -27% 01 Apr 2022 30 Jun 2022
Q1 2022 5.8% +1.2% +25% 01 Jan 2022 31 Mar 2022
Q4 2021 7.9% -3.3% -29% 01 Oct 2021 31 Dec 2021
Q3 2021 6% -10% -63% 01 Jul 2021 30 Sep 2021
Q2 2021 5.2% -16% -75% 01 Apr 2021 30 Jun 2021
Q1 2021 4.6% -22% -83% 01 Jan 2021 31 Mar 2021
Q4 2020 11% +228% 01 Oct 2020 31 Dec 2020
Q3 2020 16% 01 Jul 2020 30 Sep 2020
Q2 2020 21% 01 Apr 2020 30 Jun 2020
Q1 2020 27% 01 Jan 2020 31 Mar 2020
Q4 2019 -217% 01 Oct 2019 31 Dec 2019

BioNexus Gene Lab Corp Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 -17% +10% +38% 01 Jan 2024 31 Dec 2024
2023 -27% -24% -896% 01 Jan 2023 31 Dec 2023
2022 -2.7% -11% -134% 01 Jan 2022 31 Dec 2022
2021 7.9% -3.3% -29% 01 Jan 2021 31 Dec 2021
2020 11% +228% 01 Jan 2020 31 Dec 2020
2019 -217% -245% -870% 01 Jan 2019 31 Dec 2019
2018 28% 01 Jan 2018 31 Dec 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.